mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases. (2018)

First Author: Walters HE
Attributed to:  Synthetic viability: a novel approach to defining healthspan determinants funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/ijms19082325

PubMed Identifier: 30096787

Publication URI: http://europepmc.org/abstract/MED/30096787

Type: Journal Article/Review

Volume: 19

Parent Publication: International journal of molecular sciences

Issue: 8

ISSN: 1422-0067